Authors say people with normal-tension glaucoma should be screened for Alzheimer disease
WEDNESDAY, Oct. 12, 2022 (HealthDay News) — People with normal-tension glaucoma (NTG) have an increased risk for developing Alzheimer disease, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Sept. 30 to Oct. 3 in Chicago.
Yu-Yen Chen, M.D., from Taichung Veterans General Hospital in Taiwan, and colleagues used the Taiwan National Health Insurance Research Database (2001 through 2013) to identify 15,317 individuals with NTG and 61,268 age- and gender-matched individuals without glaucoma.
The researchers found that when adjusting for confounders, the NTG group had a significantly higher risk for Alzheimer disease (adjusted hazard ratio, 1.52). Incidence was highest among those who were older, were female, or had a history of stroke. Among those in the NTG group, none of the glaucoma eyedrops used were significant risk factors or protective factors for Alzheimer disease.
“From a public health perspective, policy makers are encouraged to enforce Alzheimer’s screening for at-risk patients with normal-tension glaucoma and to provide more substantial and integrated care,” Chen said in a statement.
Statin Use Linked to Lower Risk for Glaucoma Incidence 
Ambient Temperature Linked to Intraocular Pressure in Glaucoma 
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline 
Insomnia Linked to Increased Risk for Stroke, Odds of Admission 
Increased Dementia Risk Seen After Transient Ischemic Attack .jpg)
